Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Viracta Therapeutics (OTC:VIRX) through any online brokerage.
There are no as such competitors for Viracta Therapeutics.
Viracta Therapeutics has a consensus price target of $5.04.
The stock price for Viracta Therapeutics (OTC: VIRX) is $0.00978 last updated July 16, 2025 at 3:40 PM EDT.
There are no upcoming dividends for Viracta Therapeutics.
Viracta Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Viracta Therapeutics.
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTC.